Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2014
06/26/2014WO2014053910A3 Gall wasp control agents
06/26/2014WO2014052447A3 Methods and compositions for increasing resistance to nematodes in plants
06/26/2014WO2014047653A3 Methods and compositions for extending shelf life of plant products
06/26/2014WO2014036345A3 Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
06/26/2014WO2013095014A8 Method for detecting compound-binding protein
06/26/2014US20140182018 Combinations of Cry1Ab and Cry1Fa as an insect resistance management tool
06/26/2014US20140182017 Molecular markers of plant embryogenesis
06/26/2014US20140182015 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
06/26/2014US20140182014 Isolated eIF-5A and Polynucleotides Encoding Same
06/26/2014US20140182012 Nanocarrier based plant transfection and transduction
06/26/2014US20140182011 Methods Using Acyl-Coenzyme A-Binding Proteins to Enchance Drought Tolerance in Genetically Modified Plants
06/26/2014US20140182010 Yield traits for maize
06/26/2014US20140182007 Hybrid carrot variety nun 85021 cac
06/26/2014US20140182006 Hybrid carrot varity NUN 89201
06/26/2014US20140179911 Methods and means for the manufacture of hyaluronan
06/26/2014US20140179909 Microfluidic device for nucleic acid extraction and fractionation
06/26/2014US20140179908 Chromatography column and method for isolating nucleic acid
06/26/2014US20140179770 Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
06/26/2014US20140179769 Cancer-cell-specific cytostatic agent
06/26/2014US20140179768 ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
06/26/2014US20140179767 Methods for the treatment of leber congenital amaurosis
06/26/2014US20140179765 Phase changing formulations of nucleic acid payloads
06/26/2014US20140179764 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
06/26/2014US20140179763 Reduction of alms1 gene expression or inhibition of altrom protein to induce cardiomyocyte proliferation
06/26/2014US20140179762 METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
06/26/2014US20140179760 In vivo production of small interfering rnas that mediate gene silencing
06/26/2014US20140179759 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
06/26/2014US20140179758 Prna mutlivalent junction domain for use in stable multivalent rna nanoparticles
06/26/2014US20140179757 Nucleic acids involved in viral infection
06/26/2014US20140179756 Modified sirna molecules and uses thereof
06/26/2014US20140179611 Tribonectins
06/26/2014US20140179596 Albumin fusion proteins
06/26/2014US20140179563 Method and Nucleic Acids for the Analysis of Colorectal Cell Proliferative Disorders
06/26/2014US20140179551 Methods for the selection of binding proteins
06/26/2014US20140179547 Methods For The Generation Of Multispecific And Multivalent Antibodies
06/26/2014US20140179007 Expression of granular starch hydrolyzing enzyme in trichoderma
06/26/2014US20140179006 Crispr-cas component systems, methods and compositions for sequence manipulation
06/26/2014US20140179005 Methods and Products for Producing Engineered Mammalian Cell Lines With Amplified Transgenes
06/26/2014US20140179004 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
06/26/2014US20140179003 Alternative export pathways for vector expressed rna interference
06/26/2014US20140179002 Terminator sequence-containing reverse primer for overexpression and linear dna
06/26/2014US20140179001 Crowding agent-induced nucleic acid transfer into a recipient host cell
06/26/2014US20140178986 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/26/2014US20140178982 Reagent supply device for analysis of nucleic acid
06/26/2014US20140178974 Transportation device
06/26/2014US20140178973 Cyanobacterium sp. Host Cell and Vector for Production of Chemical Compounds in Cyanobacterial Cultures
06/26/2014US20140178965 Transiently immortalized cells for use in gene therapy
06/26/2014US20140178957 Method for amplifying the pentose phosphate pathway in yeast strains, the resulting yeast and uses thereof
06/26/2014US20140178955 Butanol fermentation using acid pretreated biomass
06/26/2014US20140178954 Expression of xylose isomerase activity in yeast
06/26/2014US20140178949 Adipate (ester or thioester) synthesis
06/26/2014US20140178941 Methods for nucleic acid manipulation
06/26/2014US20140178933 Enhanced heterologous protein production in kluyveromyces marxianus
06/26/2014US20140178932 High throughput transfection of filamentous fungi
06/26/2014US20140178930 Method for Stable Gene-Amplification in a Bacterial Host Cell
06/26/2014US20140178879 Compositions and Methods for Modifying Cells
06/26/2014US20140178561 Potatoes with reduced cold-induced sweetening
06/26/2014US20140178422 Primary mesenchymal stem cells as a vaccine platform
06/26/2014US20140178408 Method of producing an antibody
06/26/2014US20140178403 Method of inhibiting binding or activity of mif by administering a mif antagonist
06/26/2014US20140178399 Role of adam10 and its relevance to disease and therapeutics
06/26/2014US20140178392 Nogo Receptor-Mediated Blockade of Axonal Growth
06/26/2014US20140178386 Functionalized polypeptides
06/26/2014US20140178370 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
06/26/2014US20140178362 Methods and compositions for treating diseases targeting maba
06/26/2014US20140178309 Protection of cells from alu-rna-induced degeneration and inhibitors for protecting cells
06/26/2014US20140178295 Method for Treating Psoriasis By Administering An Anti-IL-12 Antibody
06/26/2014DE212011100195U9 Antikörper, der das Tumorwachstum stoppt oder verzögert (Varianten) Antibody will stop tumor growth and delayed (variants)
06/26/2014DE102008023297B4 Verfahren zur Anreicherung und Isolierung von Nukleinsäuren oder Viren Process for the enrichment and isolation of nucleic acids or viruses
06/25/2014EP2746400A1 Preparation of amines and diamines from a carboxylic acid or dicarboxylic acid or a monoester thereof
06/25/2014EP2746396A1 Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
06/25/2014EP2746395A1 Primer set, method for amplifying target nucleic acid sequence using same, and method for detecting mutated nucleic acid using same
06/25/2014EP2746394A1 Antibody and antibody-containing composition
06/25/2014EP2746393A1 Receptor gene for peptide cancer antigen-specific t cell
06/25/2014EP2746391A1 Method for producing a recombinant protein of interest
06/25/2014EP2746390A1 Method for producing a recombinant protein of interest
06/25/2014EP2745679A1 Brassica plants resistant to clubroot
06/25/2014EP2744931A1 Soluble polypeptides
06/25/2014EP2744919A2 Gene signatures for lung cancer prognosis and therapy selection
06/25/2014EP2744918A1 Yeast-muc1 immunotherapeutic compositions and uses thereof
06/25/2014EP2744916A1 Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample
06/25/2014EP2744905A1 Methods and compositions for introduction of exogenous dsrna into plant cells
06/25/2014EP2744904A1 Recombinant microorganisms for production c4-dicarboxylic acids
06/25/2014EP2744903A1 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
06/25/2014EP2744902A1 Isolation of factors that associate directly or indirectly with non-coding rnas
06/25/2014EP2744901A1 Composition and methods for rt-pcr comprising an anionic polymer
06/25/2014EP2744894A2 Production of infectious rna viruses in yeast
06/25/2014EP2744831A2 Transferrin-tumstatin fusion protein and methods for producing and using the same
06/25/2014EP2744828A1 Jaml specific binding agents, antibodies, and uses related thereto
06/25/2014EP2744818A2 Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria
06/25/2014CN103890246A 可溶性多肽 Soluble polypeptides
06/25/2014CN103890190A Hla基因的dna分型方法和试剂盒 Dna typing methods and kits Hla gene
06/25/2014CN103890187A 使用辅酶a转移酶的有机酸的制造方法 The method of manufacturing an organic acid coenzyme a transferase enzyme
06/25/2014CN103890183A 编码传染性喉气管炎病毒和新城疫病毒抗原的重组非致病性马立克氏病病毒构建体 Recombinant non-pathogenic Marek's disease virus-encoded ILT virus and Newcastle disease virus antigen constructs
06/25/2014CN103890182A 具有增强的产量相关性状的植物和其生产方法 Plant and its production method having enhanced yield-related traits
06/25/2014CN103890181A 修饰植物基因组的方法和手段 The method and means of modifying the plant genome
06/25/2014CN103890180A 在丝状真菌宿主细胞中产生多种重组多肽的方法 Produce a variety of recombinant polypeptides in a filamentous fungal host cell method
06/25/2014CN103890179A 使用人工微rna沉默基因的方法和组合物 Micro-rna gene silencing using artificial methods and compositions
06/25/2014CN103890178A 转化微生物如巴斯德毕赤酵母中多亚基蛋白如抗体的高滴度和高纯度生成的多拷贝方案 Transformed microorganisms such as a multi-copy Pichia pastoris program multimeric proteins such as antibodies of high titer and high purity generated
06/25/2014CN103890177A Hpv嵌合颗粒 Hpv chimeric particles